Product
DELSTRIGO
1 clinical trial
1 indication
Indication
HIVClinical trial
Switch From Stable cART Containing ABA/3TC or TAF/FTC Plus Dolutegravir or Bictegravir to TDF/3TC/Doravirine in People Living With HIV: Impact on Lipids, Body Composition, Insulin Sensitivity, Neuroendocrine Function and Inflammation MarkersStatus: Recruiting, Estimated PCD: 2024-06-01